Stock HUNAN TIANYI SCIENCE AND TECH. CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Hunan Tianyi Science and Tech. Co., Ltd Shenzhen S.E.

Equities

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
- - Intraday chart for Hunan Tianyi Science and Tech. Co., Ltd
04-29 Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-29 Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Hunan Jingfeng Pharmaceutical Co.,Ltd., formerly Hunan Tianyi Science and Technology Co., Ltd, is a China-based company principally engaged in the research, development, manufacture and sale of chemical drugs, biochemical drugs and traditional Chinese patent drugs. The Company's main products includes cardio and cerebrovascular drugs, antihypertensive and hypolipidemic drugs, orthopedic drugs, anti-tumor products, endocrine drugs, digestive system drugs, antiviral drugs and anti-infective drugs, among others. The Company is also involved in commodity import and export trading, business management and consulting, as well as medical technology consulting business. The Company distributes its products in the domestic market.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Injection
57.3 %
519 61.7 % 377 57.3 % -27.39%
Solid Preparations
28.1 %
201 23.9 % 185 28.1 % -8.22%
Other
14.6 %
118 14.0 % 96 14.6 % -18.89%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
841 100.0 % 657 100.0 % -21.86%

Managers

Managers TitleAgeSince
Xiang Wu Ye FOU
 Founder 72 08/12/98
Yuan Bi BRD
 Director/Board Member 36 19/07/18
Min Chen IRC
 Investor Relations Contact 45 -
Xian Peng Ma PRN
 Corporate Officer/Principal 45 27/12/17

Members of the board

Members of the board TitleAgeSince
Xiang Wu Ye FOU
 Founder 72 08/12/98
Xiong Wen Hu BRD
 Director/Board Member 58 28/12/14
Yuan Bi BRD
 Director/Board Member 36 19/07/18
Shu Qing Xie BRD
 Director/Board Member 56 25/01/21
Xiao Qing Teng CHM
 Chairman 59 25/01/21
Ting Liu BRD
 Director/Board Member 43 23/04/23
Pei Yi Di BRD
 Director/Board Member 39 23/04/23
Shao Xian Zhong BRD
 Director/Board Member 50 27/10/21
Shen Dong Zhou BRD
 Director/Board Member 33 06/04/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 879,774,351 732,508,233 ( 83.26 %) 0 83.26 %

Shareholders

NameEquities%Valuation
China Asset Management Co., Ltd.
0.0445 %
314,800 0.0445 % 109 761
Sealand Securities Co., Ltd. (Investment Management)
0.008302 %
58,700 0.008302 % 20 467
Essence Fund Co., Ltd.
0.004540 %
32,100 0.004540 % 11 192
CICC Fund Management Ltd.
0.000933 %
6,600 0.000933 % 2 301

Company contact information

Hunan Jingfeng Pharmaceutical Co., Ltd.

Room 9-1, 9th Floor, Building C Federation of Industry & Commerce

265701, Yantai

+86 21 6686 1001

http://www.jfyiyao.com
address Hunan Tianyi Science and Tech. Co., Ltd

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.95% 700B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 569B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.97% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.83% 330B
ABBVIE INC. Stock AbbVie Inc.
+3.54% 287B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.70% 236B
NOVARTIS AG Stock Novartis AG
+6.68% 202B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 197B
AMGEN INC. Stock Amgen Inc.
+6.70% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000908 Stock
  4. Stock
  5. Company Hunan Tianyi Science and Tech. Co., Ltd